Corporate News     14-Nov-17 Board of Gulshan Polyols recommends interim dividend Of Rs 0.4 per share Gulshan Polyols announced that the Board of Directors of the Company at its meeting held on 13 November 2017, inter alia, have recommended the interim dividend of Rs 0.4 per equity Share (i.e. 40%) , subject to the approval of the shareholders. Previous News   Gulshan Polyols  ( Results - Analysis 21-May-22   07:37 )   Gulshan Polyols consolidated net profit rises 121.23% in the June 2024 quarter  ( Results - Announcements 14-Aug-24   07:38 )   Gulshan Polyols appoints senior management  ( Corporate News - 13-Jan-24   11:09 )   Gulshan Polyols standalone net profit rises 198.43% in the September 2020 quarter  ( Results - Announcements 03-Nov-20   08:01 )   Gulshan Polyols standalone net profit rises 5.90% in the September 2019 quarter  ( Results - Announcements 15-Nov-19   08:02 )   Gulshan Polyols consolidated net profit declines 57.02% in the June 2023 quarter  ( Results - Announcements 05-Aug-23   07:32 )   Gulshan Polyols announces change in company secretary and compliance officer  ( Corporate News - 30-Jan-21   12:46 )   Gulshan Polyols to convene EGM  ( Corporate News - 20-Aug-21   11:55 )   Gulshan Polyols to conduct AGM  ( Corporate News - 06-Sep-23   14:01 )   Gulshan Polyols standalone net profit declines 37.80% in the December 2022 quarter  ( Results - Announcements 18-Jan-23   07:36 )   Gulshan Polyols net profit rises 19.12% in the June 2013 quarter  ( Results - Announcements 05-Aug-13   09:04 )	Other Stories   Board of HCL Technologies recommends Interim Dividend   14-Jul-25   17:52   Objectone Information Systems to conduct board meeting   14-Jul-25   17:50   JTEKT India AGM scheduled   14-Jul-25   17:50   Setco Automotive to discuss results   14-Jul-25   17:50   Saurashtra Cement to hold board meeting   14-Jul-25   17:49   John Cockerill India to table results   14-Jul-25   17:49   ATV Projects India to conduct board meeting   14-Jul-25   17:49   Shilchar Technologies schedules AGM   14-Jul-25   17:49   Sun Pharma settles litigation related to LEQSELVI™ with Incyte   14-Jul-25   16:53   Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States   14-Jul-25   16:48
Back Top